Literature DB >> 20452032

Anti-sperm antibodies are not associated with sperm DNA damage: a prospective study of infertile men.

Armand Zini1, Simon Phillips, Josee Lefebvre, Abdulaziz Baazeem, Francois Bissonnette, Isaac Jacques Kadoch, Maria San Gabriel.   

Abstract

Infertile men have poorer sperm DNA integrity than do fertile men, and this damage may contribute to reducing male reproductive potential. However, the etiology of this damage has not been fully characterized. We sought to examine the relationship, if any, between anti-sperm antibodies and sperm DNA damage in a consecutive series of non-azoospermic, infertile men in order to determine whether anti-sperm antibodies (ASAs) may contribute to sperm DNA damage. We conducted a prospective study on consecutive semen samples obtained from men (n=75) presenting for infertility evaluation. Sperm concentration, motility, strict morphology, ASA levels (by direct mixed agglutination reaction, expressed as the percentage of spermatozoa with IgG or IgA antibodies) and sperm DNA damage (by sperm chromatin structure assay) were evaluated. Mean (+/-SD) sperm concentration and progressive motility were significantly lower in ASA-positive (>40% of sperm coated with ASAs) compared to ASA-negative samples (23.4+/-13.1 x 10(6)/mL and 27+/-15% vs. 74.6+/-61.2 x 10(6)/mL and 46+/-18%, respectively, P<0.05). Sperm progressive motility was inversely correlated with the percentage of IgG-bound (r=-0.33) and IgA-bound spermatozoa (r=-0.25). In contrast, sperm %DNA fragmentation index and percent normal forms were not significantly different in ASA-positive compared to ASA-negative samples (17.5+/-17.9% and 7.5+/-3.0% vs. 17.4+/-13.5% and 6.5+/-2.6%, respectively). The data indicate that ASAs are not associated with sperm DNA damage and suggest that ASAs are unlikely to have a significant direct or indirect effect on sperm DNA integrity. Copyright (c) 2010 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20452032     DOI: 10.1016/j.jri.2010.03.006

Source DB:  PubMed          Journal:  J Reprod Immunol        ISSN: 0165-0378            Impact factor:   4.054


  5 in total

Review 1.  Medical therapy for spermatogenic failure.

Authors:  Ranjith Ramasamy; Peter J Stahl; Peter N Schlegel
Journal:  Asian J Androl       Date:  2011-12-19       Impact factor: 3.285

Review 2.  A Short Review on Growth and Endocrine Long-term Complications in Children and Adolescents with β-Thalassemia Major: Conventional Treatment versus Hematopoietic Stem Cell Transplantation.

Authors:  Shayma Ahmed; Ashraf Soliman; Vincenzo De Sanctis; Nada Alaaraj; Fawzia Alyafei; Noor Hamed; Mohamed Yassin
Journal:  Acta Biomed       Date:  2022-08-31

3.  A novel protein biochip screening serum anti-sperm antibody expression and natural pregnancy rate in a follow-up study in Chinese infertility.

Authors:  Feihong Xu; Lei Ye; Yuan Hu; Chengyun Cai; Zhen Wang; Liqing Fan; Lihua Song; Zhenshan Xu; Weidong Du
Journal:  Biosci Rep       Date:  2020-02-28       Impact factor: 3.840

Review 4.  Role of Antisperm Antibodies in Infertility, Pregnancy, and Potential forContraceptive and Antifertility Vaccine Designs: Research Progress and Pioneering Vision.

Authors:  Vickram A S; Kuldeep Dhama; Sandip Chakraborty; Hari Abdul Samad; Shyma K Latheef; Khan Sharun; Sandip Kumar Khurana; Archana K; Ruchi Tiwari; Prakash Bhatt; Vyshali K; Wanpen Chaicumpa
Journal:  Vaccines (Basel)       Date:  2019-09-16

Review 5.  Thoughts on the popularity of ICSI.

Authors:  Mounia Haddad; Joshua Stewart; Philip Xie; Stephanie Cheung; Aysha Trout; Derek Keating; Alessandra Parrella; Sherina Lawrence; Zev Rosenwaks; Gianpiero D Palermo
Journal:  J Assist Reprod Genet       Date:  2020-11-06       Impact factor: 3.412

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.